Proceedings of 42nd AGM are enclosed herewith
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals held its 42nd AGM on September 9, 2025, at 12:00 noon via video conferencing, with 36 members in attendance. The Managing Director, Mr. Ramesh Arora, chaired the meeting and gave an overview of the company's financial performance for FY 2024-25 and its growth plans. A total of 11 resolutions were put to vote, including adoption of audited financial statements, re-appointment of three whole-time directors and the Managing Director with remuneration, appointment of two independent directors, and ratification of secretarial and cost auditors. Both remote e-voting (September 6–8, 2025) and e-voting during the meeting were conducted, with M/s Rishi Mittal & Associates acting as scrutinizer. The voting results will be filed separately with BSE within the prescribed timeline. The meeting concluded at 12:50 PM.
Routine AGM proceedings with standard re-appointments of the promoter-family directors (Arora family) and key managerial personnel. No major strategic or financial surprise disclosed; voting results awaited, but no contentious items flagged. Neutral impact on shareholders pending the formal voting outcome.